MARKET

CDXC

CDXC

Chromadex Corp
NASDAQ
1.560
+0.040
+2.63%
Closed 16:00 06/05 EDT
OPEN
1.520
PREV CLOSE
1.520
HIGH
1.589
LOW
1.490
VOLUME
95.80K
TURNOVER
82.42K
52 WEEK HIGH
2.370
52 WEEK LOW
1.150
MARKET CAP
116.95M
P/E (TTM)
-10.2228
1D
5D
1M
3M
1Y
5Y
Chromadex Corp: Statement of changes in beneficial ownership of securities
Press release · 4d ago
ChromaDex (CDXC) Reports Q1 Loss, Tops Revenue Estimates
NASDAQ · 05/10 21:35
Recap: ChromaDex Q1 Earnings
Benzinga · 05/10 21:10
Earnings Scheduled For May 10, 2023
Benzinga · 05/10 13:12
Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Lags Revenue Estimates
NASDAQ · 05/09 21:45
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Tops Revenue Estimates
NASDAQ · 05/08 21:15
HC Wainwright & Co. Maintains Buy on ChromaDex, Lowers Price Target to $5
Benzinga · 03/13 10:20
HC Wainwright Adjusts Price Target on ChromaDex to $5 From $5.50, Keeps Buy Rating
HC Wainwright Adjusts Price Target on ChromaDex to $5 From $5.50, Keeps Buy Rating
MT Newswires · 03/13 07:36
More
About CDXC
Chromadex Corp. is a bioscience company, which is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain its ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. It provides Niagen in ingredient form to its strategic partners. It provides Niagen in ingredient form to its strategic partners. It also offers Immulina, which is a spirulina extract. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Webull offers kinds of Chromadex Corp stock information, including NASDAQ:CDXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CDXC stock methods without spending real money on the virtual paper trading platform.